| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ISHARES TR | 31,600 | 10,691,000 | 7.06% | ||
| 2 | ALKERMES PLC SHS | 87,415 | 6,939,000 | 4.58% | ||
| 3 | IONIS PHARMACEUTICALS INC | 102,459 | 6,345,000 | 4.19% | ||
| 4 | ALEXION PHARMACEUTIC | 32,969 | 6,289,000 | 4.15% | ||
| 5 | NEKTAR THERAPEUTICS COM | 348,583 | 5,874,000 | 3.88% | ||
| 6 | REGENERON PHARMACEUTICALS | 10,714 | 5,816,000 | 3.84% | ||
| 7 | AMGEN INC | 35,773 | 5,807,000 | 3.84% | ||
| 8 | CELGENE CORP | 47,956 | 5,743,000 | 3.79% | ||
| 9 | SEATTLE GENETICS INC | 127,088 | 5,704,000 | 3.77% | ||
| 10 | BRISTOL MYERS SQUIBB CO | 77,100 | 5,304,000 | 3.50% | ||
| 11 | VERTEX PHARMACEUT | 41,662 | 5,242,000 | 3.46% | ||
| 12 | INCYTE | 48,045 | 5,210,000 | 3.44% | ||
| 13 | MERCK & CO INC | 90,000 | 4,754,000 | 3.14% | ||
| 14 | ALNYLAM PHARMACEUTICALS INC | 50,222 | 4,728,000 | 3.12% | ||
| 15 | BIOMARIN | 43,870 | 4,596,000 | 3.04% | ||
| 16 | QIAGEN NV | 160,000 | 4,424,000 | 2.92% | ||
| 17 | MEDIVATION INC | 91,310 | 4,414,000 | 2.92% | ||
| 18 | ILLUMINA INC | 22,643 | 4,346,000 | 2.87% | ||
| 19 | GILEAD SCIENCES INC | 33,700 | 3,410,000 | 2.25% | ||
| 20 | METTLER-TOLEDO | 9,700 | 3,290,000 | 2.17% | ||
| 21 | BIOGEN INC | 10,482 | 3,211,000 | 2.12% | ||
| 22 | ADAMAS PHARMACEUTICALS INC | 80,000 | 2,266,000 | 1.50% | ||
| 23 | AGIOS PHARMACEUTICALS INC | 34,000 | 2,207,000 | 1.46% | ||
| 24 | EPIZYME INC COM | 135,627 | 2,173,000 | 1.44% | ||
| 25 | HOLOGIC INC | 48,000 | 1,857,000 | 1.23% | ||
| 26 | CLOVIS ONCOLOGY INC | 50,000 | 1,750,000 | 1.16% | ||
| 27 | LOXO ONCOLOGY INC COM | 60,000 | 1,707,000 | 1.13% | ||
| 28 | ASTRAZENECA PLC | 49,100 | 1,667,000 | 1.10% | ||
| 29 | NANOSTRING TECHNOLOGIES INC | 102,200 | 1,503,000 | 0.99% | ||
| 30 | PACIRA BIOSCIENCES INC | 19,110 | 1,467,000 | 0.97% | ||
| 31 | ZOGENIX INC | 95,700 | 1,411,000 | 0.93% | ||
| 32 | IGNYTA INC COM | 100,000 | 1,340,000 | 0.89% | ||
| 33 | OPHTHOTECH CORP COM | 17,000 | 1,335,000 | 0.88% | ||
| 34 | XENCOR INC COM | 90,000 | 1,316,000 | 0.87% | ||
| 35 | Dicerna Pharmaceuticals | 100,000 | 1,187,000 | 0.78% | ||
| 36 | SERES THERAPEUTICS INC | 33,000 | 1,158,000 | 0.77% | ||
| 37 | PARATEK PHARMACEUTICALS INC | 60,000 | 1,138,000 | 0.75% | ||
| 38 | ACHILLION PHARMACEUTICALS INC COM | 100,000 | 1,079,000 | 0.71% | ||
| 39 | PROSHARES TR | 14,919 | 1,067,000 | 0.70% | ||
| 40 | BIOCRYST PHARMACEUTICALS | 100,000 | 1,032,000 | 0.68% | ||
| 41 | UNITED THERAPEUTICS | 6,514 | 1,020,000 | 0.67% | ||
| 42 | SANOFI SPOND FUNSPONSORED ADR | 122,500 | 968,000 | 0.64% | ||
| 43 | MEDICINES CO | 25,000 | 934,000 | 0.62% | ||
| 44 | MACROGENICS INC | 30,000 | 929,000 | 0.61% | ||
| 45 | VERICEL CORP | 332,157 | 857,000 | 0.57% | ||
| 46 | NOVAVAX INC COM | 100,000 | 839,000 | 0.55% | Put | |
| 47 | NOVAVAX INC COM | 100,000 | 839,000 | 0.55% | Call | |
| 48 | KARYOPHARM THERAPEUTICS INC COM | 60,000 | 795,000 | 0.53% | ||
| 49 | FLUIDIGM CORP DEL COM | 70,000 | 757,000 | 0.50% | ||
| 50 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 56,788 | 693,000 | 0.46% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-16-004260, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
